Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience
- PMID: 18405241
Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience
Abstract
Objectives: Renal dysfunction is one of the most significant complications after liver transplant. It is attributed mainly to nephrotoxicity caused by calcineurin inhibitors. We evaluated the renal functioning in liver transplant recipients alive for at least 6 months after liver transplant.
Materials and methods: One hundred seventy patients (108 male [63.5%], 62 female [36.5%]; mean age, 31.4 +/- 13.3 years; age range, 13-61 years) were included in this study. Patients who had undergone a liver transplant between 1994 and 2006 at the Organ Transplantation Center of the Shiraz University of Medical Sciences in Shiraz, Iran, and had been alive for at least 6 months after surgery were included. Data were collected regarding age, sex, body mass index, underlying liver disease, graft type, immunosuppressive medications, serum creatinine levels, and glomerular filtration rate before, 1, and 6 months after liver transplant. Renal dysfunction was defined as a serum creatinine level above 132.6 micromol/L or a glomerular filtration rate less than 60 mL/min/1.73 m2, based on our reference range. Glomerular filtration rate was calculated using the Schwartz formula (glomerular filtration rate mL/min/1.73 m2 = K x Ht (cm) / Cr mg/dL). Data were analyzed with SPSS software.
Results: The mean follow-up was 25.9 +/- 23.5 months (range, 6-156 months). The main indications for liver transplant were cryptogenic cirrhosis (n=42), hepatitis B infection (n=34), autoimmune cirrhosis (n=30), Wilson's disease (n=21), and primary sclerosing cholangitis (n=18). The mean pretransplant glomerular filtration rate was 93.7 +/- 35.6 mL/min/1.73 m2. The mean glomerular filtration rates in the first and sixth months after liver transplant were 81.6 +/- 29.3 mL/min/1.73 m2 and 83.6 +/- 32.9 mL/min/1.73 m2. Sex, body mass index, type of immunosuppressive medication, and underlying liver disease were not predictors of renal dysfunction (P > .05). Posttransplant renal dysfunction was significantly more common in older patients (ie, those aged 38.8 years and older) (P = .0001) and those with a family history of renal disease (P < .05).
Conclusions: Renal dysfunction may be a significant problem for patients after liver transplant, and early detection of renal dysfunction in patients after liver transplant is important. Of all the risk factors studied here, only older age and family history of renal disease were correlated with development of renal dysfunction after liver transplant.
Similar articles
-
Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.Liver Transpl. 2009 Dec;15(12):1792-7. doi: 10.1002/lt.21920. Liver Transpl. 2009. PMID: 19938140 Clinical Trial.
-
Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.Dig Liver Dis. 2009 May;41(5):350-6. doi: 10.1016/j.dld.2008.09.018. Epub 2008 Nov 28. Dig Liver Dis. 2009. PMID: 19046932
-
Independent risk factors and natural history of renal dysfunction in liver transplant recipients.Liver Transpl. 2003 Jul;9(7):741-7. doi: 10.1053/jlts.2003.50113. Liver Transpl. 2003. PMID: 12827563
-
Renal function in pediatric liver transplant patients.Kidney Int Suppl. 1996 Jan;53:S77-84. Kidney Int Suppl. 1996. PMID: 8770996 Review.
-
Cyclosporine-A-based immunosuppression and renal functional reserve in organ-transplant patients.Transplant Proc. 2004 Mar;36(2 Suppl):248S-250S. doi: 10.1016/j.transproceed.2003.12.040. Transplant Proc. 2004. PMID: 15041347 Review.
Cited by
-
Underestimation of chronic renal dysfunction after liver transplantation: ICEBERG study.World J Transplant. 2015 Mar 24;5(1):26-33. doi: 10.5500/wjt.v5.i1.26. World J Transplant. 2015. PMID: 25815269 Free PMC article.
-
Prevalence of primary sclerosing cholangitis (PSC) in Iranian adult patients with inflammatory bowel disease (IBD) or liver disorders: systematic review and meta-analysis.Gastroenterol Hepatol Bed Bench. 2025;18(1):10-20. doi: 10.22037/ghfbb.v18i1.3046. Gastroenterol Hepatol Bed Bench. 2025. PMID: 40734806 Free PMC article. Review.
-
Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.Drugs Aging. 2009;26(9):715-37. doi: 10.2165/11316480-000000000-00000. Drugs Aging. 2009. PMID: 19728747 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical